Skip to main content
. 2020 Oct 7;11:545555. doi: 10.3389/fphar.2020.545555

Table 2.

Incidence rate of hypersensitivity reaction and anaphylactic shock.

Hypersensitivity reaction Incidence rate (95% CI)
By subjects (15 of 8,580)Male (7 of 4,081)Female (8 of 4,499) 0.175% (0.086–0.263)0.172% (0.045–0.298)0.178% (0.055–0.301)
By treatments (15 of 60,654)Male (7 of 28,626)Female (8 of 32,028) 0.025% (0.012–0.037)0.024% (0.006–0.043)0.025% (0.008–0.042)
Anaphylaxis shock Incidence rate (95% CI)
By subjects (4 of 8,580)
Male (1 of 4,081)Female (3 of 4,49
0.047% (0.001–0.092)
0.025% (-0.024–0.073)
0.067% (-0.009–0.142)
By treatments (4 of 60,654)
Male (1 of 28,626)
Female (3 of 32,028)
0.007% (0.000–0.013)
0.003% (-0.003–0.010)
0.009% (-0.001–0.020)
Severity of symptom Frequency (%)
Grade 1 (Mild)Grade 2 (Moderate)Grade 3 (Severe) 6 (male 4, female 2), 40.0%7 (male 3, female 4), 46.7%2 (male 0, female 2), 13.3%